Dec-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Amend Cannabis has shown a varied performance across different product categories and states, particularly in Missouri. In the Tincture & Sublingual category, the brand achieved a commendable fifth place ranking in September 2024, but its absence from the top 30 in the following months indicates a significant drop in market presence. This could suggest either a shift in consumer preferences or increased competition within the category. The lack of ranking data for subsequent months highlights a potential area of concern for the brand, as maintaining a top position is crucial for sustained visibility and sales in the competitive cannabis market.
In contrast, Amend Cannabis has maintained a more consistent performance in the Topical category in Missouri. The brand held steady at the fifth position in both September and October 2024, before slightly dropping to sixth place in November and December 2024. Despite the decline in sales from October to December, the ability to remain in the top 10 suggests a resilient market position. This consistency could be attributed to loyal customer base or successful marketing strategies that have resonated with consumers. The fluctuations in sales figures, however, indicate room for improvement in maintaining or growing their market share in the Topical category.
Competitive Landscape
In the Missouri topical cannabis market, Amend Cannabis has experienced a notable shift in its competitive positioning over the last few months of 2024. While Amend Cannabis maintained a consistent rank of 5th place in September and October, it slipped to 6th place in both November and December. This decline in rank coincides with a downward trend in sales, indicating potential challenges in maintaining market share. In contrast, Vlasic Labs has shown a positive trajectory, climbing from 6th to 4th place by December, with a corresponding increase in sales. Meanwhile, Heartland Labs experienced a slight decline in rank from 3rd to 5th place, yet their sales figures remain relatively robust compared to Amend Cannabis. These dynamics suggest that while Amend Cannabis faces competitive pressures, particularly from brands like Vlasic Labs, there is an opportunity to reassess and potentially revitalize its market strategy to regain its standing in the Missouri topical category.
Notable Products
In December 2024, the CBD/THC/CBC 1:1:1 Transdermal Lotion (500mg CBD, 500mg THC, 500mg CBC) emerged as the top-performing product for Amend Cannabis, maintaining its first-place ranking from October. This product achieved notable sales figures, with December sales reaching 112 units, showcasing its consistent appeal. The CBD/THC 1:1 Transdermal Lotion (500mg CBD, 500mg THC) slipped to second place from its top position in November, indicating a slight decline in preference. Notably, the CBD/THC 1:1 Amend Infused Balm (250mg CBD, 250mg THC) and its 50mg variant, which were previously ranked, did not appear in the December rankings, suggesting a decrease in their demand. Overall, the Transdermal Lotions continue to dominate the topical category, reflecting a strong consumer preference for these products.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.